Janus Henderson Investors US’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | $107M | Buy |
5,167,085
+230,044
| +5% | +$4.78M | 0.09% | 277 |
|
|
2016
Q4 | $103M | Buy |
4,937,041
+368,158
| +8% | +$7.66M | 0.09% | 287 |
|
|
2016
Q3 | $150M | Sell |
4,568,883
-573,127
| -11% | -$18.8M | 0.13% | 220 |
|
|
2016
Q2 | $128M | Sell |
5,142,010
-96,140
| -2% | -$2.4M | 0.11% | 248 |
|
|
2016
Q1 | $128M | Buy |
5,238,150
+356,955
| +7% | +$8.74M | 0.11% | 240 |
|
|
2015
Q4 | $161M | Buy |
4,881,195
+641,340
| +15% | +$21.2M | 0.14% | 199 |
|
|
2015
Q3 | $139M | Buy |
4,239,855
+3,376,540
| +391% | +$111M | 0.12% | 214 |
|
|
2015
Q2 | $45.7M | Buy |
+863,315
| New | +$45.7M | 0.04% | 459 |
|